Drug Repositioning: Current Advances and Future Perspectives
Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2019 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (153 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug repurposing and repositioning : : workshop summary / / Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy ; Sarah H. Beachy, rapporteurs [and three others].
Published: (2014.) -
In Silico Strategies for Prospective Drug Repositionings
by: Udrescu, Lucreția
Published: (2022) -
Drug repositioning : bringing new life to shelved assets and existing drugs / / edited by Michael J. Barratt, Donald E. Frail.
Published: (c2012.) -
Unsui : : A Diary of Zen Monastic Life / / Eshin Nishimura; ed. by Bardwell L. Smith.
by: Nishimura, Eshin,
Published: ([2021]) -
Repositioning restorative justice / edited by Lode Walgrave.
Published: (2003.)